GM-CSF Dotaz Zobrazit nápovědu
- MeSH
- dospělí MeSH
- faktor stimulující granulocyto-makrofágové kolonie aplikace a dávkování terapeutické užití MeSH
- lidé středního věku MeSH
- lidé MeSH
- lymfom farmakoterapie MeSH
- nádory farmakoterapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- přehledy MeSH
- srovnávací studie MeSH
- MeSH
- cytogenetika MeSH
- dospělí MeSH
- faktory růstu hematopoetických buněk MeSH
- krevní a lymfatické nemoci diagnóza genetika MeSH
- lidé MeSH
- myelodysplastické syndromy diagnóza genetika MeSH
- techniky in vitro MeSH
- vyšetřování kostní dřeně metody MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
European journal of cancer ; Supplement Vol. 29. 3
S17 s. : obr., grafy ; 28 cm
XI, 259 s. : bar.tab., grafy ; 24 cm
- Klíčová slova
- LEUCOMAX,
- MeSH
- CD antigeny MeSH
- dospělí MeSH
- faktor stimulující granulocyto-makrofágové kolonie terapeutické užití MeSH
- leukemie farmakoterapie imunologie komplikace MeSH
- lidé MeSH
- lymfom farmakoterapie imunologie komplikace MeSH
- mladiství MeSH
- nádory farmakoterapie imunologie komplikace MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
Závěrečná zpráva o řešení grantu Interní grantové agentury MZ ČR
93 l. : tab., grafy ; 32 cm
The grant project is aimed at a combined therapy of tumours using IL-2 and GM-CSF as recombinant cytokines or genetically modified tumour vaccines.
Grantový projekt je zaměřen na kombinovanou léčbu nádorů pomocí IL - 2 a GM-CSF využívající rekombinantních cytokinů a geneticky modifikovaných nádorových vakcin.
- MeSH
- faktor stimulující granulocyto-makrofágové kolonie terapeutické užití MeSH
- interleukin-2 MeSH
- kombinovaná terapie MeSH
- protinádorové vakcíny MeSH
- reziduální nádor terapie MeSH
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- biologie
- onkologie
- NLK Publikační typ
- závěrečné zprávy o řešení grantu IGA MZ ČR
Granulocyte-macrophage colony stimulating factor (GM-CSF) is considered to be the most effective immunostimulating factor for the construction of gene-engineered anti-cancer vaccines. In some tumour cells, this type of genetic modification has resulted in the loss of the oncogenic potential. This was not the case with bcr-abl-transformed mouse 12B1 cells. A cell line, designated 12B1/GM-CSF/cl-5 producing more than 100 ng/106 cells/24 h, displayed higher pathogenicity than the parental, non-transduced cells. Although the tumours induced by the parental 12B1 cells and 12B1/GM-CSF/cl-5 cells appeared nearly at the same time and then grew at an approximately equal rate, the latter mice were in a much poorer clinical condition. In these animals the growth of the tumours was associated with gradually increasing blood levels of GM-CSF. In both groups of animals splenomegaly was observed; it was much more pronounced in the case of 12B1/GM-CSF/cl-5-inoculated animals. While in the case of animals inoculated with the parental cells the splenomegaly was probably mainly due to infiltration with tumour cells, in the animals inoculated with the GM-CSF-secreting cells splenomegaly and derangement of parenchymal organs, such as lungs, liver and kidneys, were more complex, including congestion and infiltration with hemopoietic cells, predominantly immature cells of myeloid lineage. The most conspicuous of these changes was the hyperaemia of the lungs. No such alterations were seen in animals inoculated with the parental cells. On the other hand, the contents of T regulatory cells were comparable in both groups and they increased in parallel at the end of the observation period. When GM-CSF neutralizing antibody was administered to animals inoculated with the 12B1/GM-CSF/cl-5 cells, the pathological changes observed within the organs were suppressed, this proving that the overproduced GM-CSF and not any other substance, played the key role in their induction.
- MeSH
- bcr-abl fúzové proteiny genetika metabolismus MeSH
- experimentální nádory patologie MeSH
- faktor stimulující granulocyto-makrofágové kolonie krev imunologie sekrece MeSH
- interleukin-2 sekrece MeSH
- játra patologie MeSH
- ledviny patologie MeSH
- leukemie patologie MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- neutralizující protilátky aplikace a dávkování MeSH
- plíce patologie MeSH
- regulační T-lymfocyty imunologie MeSH
- slezina imunologie patologie MeSH
- transplantace nádorů MeSH
- tumor burden MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Subversion of the host immune system by viruses is often mediated by molecular decoys that sequester host proteins pivotal to mounting effective immune responses. The widespread mammalian pathogen parapox Orf virus deploys GIF, a member of the poxvirus immune evasion superfamily, to antagonize GM-CSF (granulocyte macrophage colony-stimulating factor) and IL-2 (interleukin-2), two pleiotropic cytokines of the mammalian immune system. However, structural and mechanistic insights into the unprecedented functional duality of GIF have remained elusive. Here we reveal that GIF employs a dimeric binding platform that sequesters two copies of its target cytokines with high affinity and slow dissociation kinetics to yield distinct complexes featuring mutually exclusive interaction footprints. We illustrate how GIF serves as a competitive decoy receptor by leveraging binding hotspots underlying the cognate receptor interactions of GM-CSF and IL-2, without sharing any structural similarity with the cytokine receptors. Our findings contribute to the tracing of novel molecular mimicry mechanisms employed by pathogenic viruses.
- MeSH
- faktor stimulující granulocyto-makrofágové kolonie chemie imunologie metabolismus MeSH
- HEK293 buňky MeSH
- infekce vyvolané poxviry imunologie metabolismus virologie MeSH
- interakce hostitele a patogenu imunologie MeSH
- interleukin-2 chemie imunologie metabolismus MeSH
- krystalografie rentgenová MeSH
- lidé MeSH
- molekulární modely MeSH
- multiproteinové komplexy chemie imunologie metabolismus MeSH
- Parapoxvirus imunologie metabolismus MeSH
- vazba proteinů MeSH
- virové proteiny chemie imunologie metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
European journal of cancer, ISSN 0959-8049 vol. 35, suppl. 3, August 1999
S40 s. : il., grafy ; 30 cm
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- onkologie
- biologie
The aim of the studies was to ascertain if adenosine is able to co-operate with selected hematopoietic growth factors and cytokines, namely with granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), stem cell factor (SCF), interleukin-3 (IL-3), and interleukin-11 (IL-11), in inducing the growth of colonies from hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) from normal bone marrow cells in vitro. Adenosine was found not to produce any colonies when present in the cultures as the only potential stimulator. All the tested cytokines and growth factors were observed to induce the growth of distinct numbers of GM-CFC colonies, with the exception of IL-11. When suboptimal concentrations of the evaluated cytokines and growth factors were tested in the cultures in which various concentrations of adenosine were concomitantly present, mutually potentiating effects were found in the case of IL-3 and SCF. These results confirm the role of adenosine in regulation of granulopoiesis and predict IL-3 and SCF as candidates for further in vivo studies of their combined administration with adenosine.
- MeSH
- adenosin farmakokinetika MeSH
- cytokiny farmakokinetika chemie MeSH
- faktor růstu kmenových buněk farmakokinetika fyziologie chemie MeSH
- faktor stimulující granulocyto-makrofágové kolonie farmakokinetika fyziologie chemie MeSH
- faktory růstu hematopoetických buněk farmakokinetika MeSH
- financování vládou MeSH
- interleukiny farmakokinetika fyziologie chemie MeSH
- interpretace statistických dat MeSH
- myši inbrední C57BL MeSH
- myši inbrední CBA MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- srovnávací studie MeSH